APPLICATION OF REMYELINATING MEDICATION FOR STIMULATION OF NERVE CELLS IN CASE OF DEMYELINATING DISEASE

摘要

FIELD: medicine.;SUBSTANCE: invention relates to field of medicine. Invention describes application of remyelinating medication for obtaining medication in amount, stimulating remyelination of nerve cells in mammals, for treatment of demyelinating disease and method of stimulating remyelination of nerve cells in mammals, where medication is introduced to constantly demanding it mammal; constant introduction of remyelinating medication represents weekly or monthly introduction during period, equal to, at least, six months; and remyelinating medication represents antibody or its immunologically active enzyme, binding with alfa-4-integrin, and, in particular, antibody represents monoclonal antibody natalizumab or its immunologically active fragment.;EFFECT: application of remyelinating medication for obtaining medication in amount, stimulating remyelination of nerve cells in mammals.;26 cl, 20 tbl, 18 dwg, 381 ex